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ALPHA-CHLORALOSE EFFICACY IN CAPTURING NUISANCE WATERFOWL 
AND PIGEONS AND CURRENT STATUS OF FDA REGISTRATION 
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culture/APHIS, 6100 Columbus Avenue, Sandusky, Ohio 44870 
WILLIAM R. LANCE, Wildlife Pharmaceuticals, Inc., 1401 Duff Drive, Fort Collins, Colorado 80524 
ABSTRACT: During 1990 and 1991 we conducted safety, efficacy and clinical trials required to register alpha-chloralose 
(A-C) for capturing nuisance waterfowl and pigeons with the U.S. Food and Drug Administration (FDA). We determined the 
Most Effective Dose (MED) to be 30 and 60 mg of A-C/kg of body weight for capturing waterfowl and pigeons, respectively. 
We conducted 11 field trials in 4 states, capturing 587 waterfowl and 1,370 pigeons with 8% mortality for ducks, 0% for geese, 
and 6% for pigeons. We submitted a New Animal Drug Application to FDA in October 1991 and anticipate registration in 
1992. 
Proc. 15th Vertebrate Pest Conf. (J. E. Borrecco & R. E. Marsh, 
Editors) Published at University of Calif., Davis. 1992 
INTRODUCTION 
Domestic pigeons or rock doves (Columba livid), wa-
terfowl, [primarily Canada geese (Branta canadensis), wild 
mallards (Anas platyrhynchos), feral ducks and hybrids of 
wild and feral ducks], and coots (Fulica americana) are nui-
sance birds in many situations in the United States 
(Woronecki et al. 1990). The use of strychnine-treated baits, 
historically the most common method of reducing pigeon 
populations, was suspended by the U.S. Environmental Pro-
tection Agency in October 1988 for all “above ground” situa-
tions. Presently, there are no nationally registered toxic baits 
available for use on pigeons in the United States. Fenthion is 
still registered in toxic perch formulations for pigeons but 
there is concern over nontarget hazards of this chemical 
(Krysik 1987). Current management of nuisance waterfowl 
has consisted largely of reducing populations by trapping for 
translocation or euthanasia, nest and egg destruction, and 
hunting within the framework of current federal regulations 
(Woronecki et al. 1990). Presently there are no chemical 
products registered for alleviating waterfowl problems nor 
are there any drugs registered for capturing nuisance birds for 
relocation (Eschen and Schafer 1986). 
Alpha-chloralose (C8H11Cl3O6; A-C) was successfully 
used in the United States to capture Canada geese, mallards, 
feral and hybrid ducks, and coots from commercial and resi-
dential sites (Woronecki et al. 1990). In addition, over 600 
pigeons were captured with A-C at a dairy farm in Nevada 
with only 8% mortality (Woronecki, unpubl. date). However, 
additional research was necessary for federal registration of 
A-C through the U.S. Food and Drug Administration (FDA) 
for use on waterfowl and pigeons. Our objective was to con-
duct quality-assured safety, efficacy and clinical trials re-
quired to register A-C for capturing nuisance waterfowl and 
pigeons under an Investigational New Animal Drug Applica-
tion (INADA) with the FDA. 
This report summarizes our laboratory studies and clini-
cal field trials. All but one field trial were audited to insure 
compliance with good laboratory and clinical practices. The 
status of FDA registration of A-C is also discussed. 
METHODS 
Laboratory Studies 
The objective of these studies was to determine the Most 
Effective Dose (MED), the Therapeutic Index (TI = LD50/ 
ED50) and Certain Safety Factor (CSF=LD01/ED99) (Loibl et al. 
1988) for Canada geese (as a representative waterfowl 
species) and pigeons. The ED50 and LD50 are the dose levels 
(mg/kg) which capture and kill, respectively, 50% of the 
treated birds. We define MED as the minimum dosage neces-
sary to capture at least 95% of the treated animals. Once an 
MED (X) was selected, dosing of captive birds was done at 
the 1/2X, 1X and 3X dosage levels for a sample of birds of 
each species to examine behavioral response, blood profiles 
and tissue changes. 
Birds were captured in traps and held >2 days before 
being tested. Only adult waterfowl and pigeons were used. 
Following each test, all birds not exposed to A-C and birds 
that fully recovered from A-C treatment were released when 
suitable sites were available. Otherwise, birds were 
euthanized and buried. 
Birds were provided with food and water ad libitum. Ten 
geese were tested at each of 8 dosage levels and 4 to 10 
pigeons at each of 13 levels. Doses were administered at 1/4-
log intervals or successive dosage levels whose logarithms 
differ by a constant. Dosages were calculated according to 
bird weight and toxicant concentrations (mg/kg). Inoculated 
bread baits and liquid gavage material were made from a 
suspension of A-C and corn oil. Geese and pigeons were 
dosed using orally administered bread baits and liquid gavage 
respectively. Concentrations ranged from 218.6 to 218.9 mg 
of A-C per ml of com oil for geese and 52.1 to 53.7 mg of A-
C per ml of corn oil for pigeons. After dosing, birds were 
placed in outdoor shaded holding pens for observation. The 
effective dose parameters were the inability to avoid capture 
by hand or hand-held net, and the time after dosing required 
to render the bird capturable (Crider and McDaniel 1967, 
Martin 1967). 
Necropsy of 5 geese and 5 pigeons treated at 1X (MED) 
and 3X and of controls was conducted at day 0, 1 and 7 
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posttreatment by a pathologist from Wildlife Pharmaceuti-
cals, Inc., Fort Collins, Colorado to determine any morpho-
logical changes. Blood samples were collected at 0, 1 and 7 
days posttreatment and shipped to California Avian Labora-
tory, Citrus Heights, California to determine hematology and 
blood chemistry profiles of birds treated at 0, 1X (MED) and 
3X levels. Samples of baits and suspensions were sent to 
Affiliated Environmental Services, Sandusky, Ohio, for 
analyses of A-C levels. 
To demonstrate whether the MED determined for 
Canada geese was appropriate for other waterfowl, a labora-
tory evaluation of A-C with mallards was conducted. Wild 
mallards were captured in northern Ohio 3 weeks before test-
ing. Twelve mallards of each sex were dosed with A-C at 30 
mg/kg using orally administered bread baits. Birds were kept 
in shaded holding pens for observation for at least 1 week 
after dosing. 
All birds were maintained, dosed, sacrificed, bled, 
necropsied, and disposed of at the Denver Wildlife Research 
Center, Ohio Field Station, Sandusky, Ohio. Methodology 
for laboratory studies are described in more detail in 
Woronecki et al. (1991b) and Woronecki and Dolbcer (1991). 
A-C (99.5% a.i.) and documentation regarding purity was 
obtained from BioSynth Ag in Switzerland. 
Field Trials 
From May 1990 through December 1991, 10 field trials 
were conducted at 4 sites in Ohio, 3 sites in Nevada, 2 sites in 
North Carolina and 1 site in Arizona. Test sites included a 
business district, residential area, resort, park, golf course, 
hotel casino, airport, school, and agricultural experiment sta-
tion. Tests were arranged by and cooperatively conducted 
with U.S. Department of Agriculture, Animal Damage Con-
trol (ADC) biologists who had found other methods of allevi-
ating the specific problem situation to be unsuccessful. 
A-C-treated bread baits for capturing waterfowl were 
made from slices of fresh white sandwich bread cut into 2-3 
cm square pieces. Each 13-ml of suspension was prepared by 
mixing 1.63 g of A-C with 12 ml of corn oil. Each bread piece 
was inoculated with a calculated volume of suspension that 
would provide a MED of 28 to 31 mg A-C/kg body weight. 
The plan was to capture individual geese and ducks with 
single baits. Baits were made in small batches to maintain 
bread freshness and reduce crumbling and breaking. A 13-ml 
suspension would treat 14 to 17 baits for geese and 41 to 50 
baits for ducks. 
Corn baits treated with A-C were prepared by adding A-
C powder (1.0 mg of A-C per kernel) to corn that had been 
sized, screened and cleaned of dust and chaff. Typically, 2,000 
kernels of corn (weighing 600 to 650 g) and 2.0 g A-C were 
placed in a plastic container with a lid and shaken for at least 
30 sec to distribute the A-C evenly. Corn oil was added (10 
ml per 2,000 kernels of whole corn) and the contents mixed 
again. 
Birds were prebaited at least 1 week before any treat-
ment by spreading bait on the ground where the birds nor-
mally fed or by hand tossing bait to individual birds. Prebait 
was similar to bait used in the test. In two tests powdered 
sugar was used on the prebait to simulate A-C. During 
prcbaiting, we counted the number of target and nontarget 
animals present and estimated feeding rates. Prebaiting and 
baiting were usually conducted in the morning. Initial doses 
were calculated using the mean weight of targeted species as 
reported by Dunning (1984). Subsequent bait doses were 
based on the mean weight of initial birds captured at the bait 
site. 
Bait selection, either bread or corn, depended upon the 
number, species, and wariness of target birds. In situations 
where single baits could be selectively fed to individual wa-
terfowl, bread baits were preferred because each bird could 
be given a known amount of A-C (e.g., 1 or 2 baits to achieve 
a dose of 30 mg A-C/kg). Where large flocks of birds could 
not be individually fed (i.e., pigeons, wild waterfowl), corn 
baits containing 1 mg of A-C/kernel were spread over the bait 
site. For example, a site with 100 wild mallards (mean weight 
1.0 kg) or 150 pigeons (mean weight 0.33 kg) would receive 
3,000 kernels of corn treated with 1 mg of A-C/kernel. Theo-
retically, each duck would eat 30 kernels and obtain a dose of 
30 mg of A-C/kg and each pigeon would eat 20 kernels and 
obtain a dose of 60 mg of A-C/kg. In some situations, after 
birds consumed treated baits we attempted to keep them on 
the bait site by feeding them token amounts of untreated 
bread or corn. Untreated baits were also used to segregate or 
lure nontarget birds from target birds and treated birds from 
nontreated birds. 
At the time of baiting, we estimated the target bird popu-
lation present and the number of birds treated. Observations 
were made to determine the time of initial bait consumption, 
initial reaction to A-C, and immobilization. Treated birds 
were monitored for signs of sedation, the reaction of unaf-
fected birds to affected birds, and to prevent accidental 
drowning. Birds were captured by hand or with a long-
handled net as soon as they were sufficiently sedated. Se-
dated birds were transported in cloth bags to holding cages or 
an enclosed truck. Sedated birds were kept in cages lined with 
straw for at least 24 hours or until they recovered. All birds 
were weighed and dead birds buried. Mallards and geese 
were relocated to wildlife management areas. Domestic ducks 
were relocated or euthanized. Hybrid ducks and pigeons were 
euthanized. 
Methodologies for each field trial are described in more 
detail in Dolbeer and Cleary (1991), Dolbeer et al. (1991), 
Seamans and Cleary (1991), Woronecki et al. 1992, 
Woronecki et al. (1991a), Woronecki and Fairaizl (1991a), 
Woronecki and Fairaizl (1991b), Woronecki et al. (1991c), 
and Woronecki et al. (1991d). 
RESULTS 
Laboratory Studies 
Canada geese as a representative species of water-
fowl Doses and responses used to calculate the ED and LD 
values for orally administered bread baits treated with A-C on 
Canada geese are listed in Table 1. The ED50 for Canada 
geese was 15.5 mg/kg (95% fiducial limits were 9.0 to 19.0 
mg/kg). The MED was determined to be 30.0 mg/kg. The 
LD50 was 53.9 mg/kg (95% fiducial limits were 47.5 to 62.0 
mg/kg). The TI was 3.5 mg/kg and ranged from 2.5 to 6.9 
mg/kg. The CSF of A-C for capture of geese in this situation 
was 0.7, and the extreme case analysis of CSF based on 95% 
fiducial limits indicated the CSF ranged from 0.2 to 1.2. 
Only control geese and geese dosed at 1X (MED) and 
3X were used for hematology and serum chemistry profiles. 
Blood values were similar to those reported by Leonard 
(1982) and Shave (1986) for normal geese. Samples from 3X 
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Table 1. Doses and responses used to calculate effective dose (ED) and lethal dose (LD) values for 
orally administered bread baits (Canada geese) or oil suspension (pigeons) treated with alpha-
chloralose (A-C), June-October 1990. 
 
 
birds were not obtained since all geese died at this level. 
Gross and histologic examination of treated geese compared 
with control geese did not reveal any identifiable, consistent 
pattern of morphological changes related to toxicity. 
Pigeons Doses and responses used to calculate ED and 
LD values for orally administered suspensions of A-C on 
pigeons are listed in Table 1. The ED50 for pigeons was 30.5 
mg/kg (95% fiducial limits were 26.1 to 34.0). The MED was 
determined to be 60 mg/kg. The LD50 was 215.0 (95% 
fiducial limits of were 180.6 to 493.6 mg/kg). The TI was 
determined to be 7.1 and ranged from 5.3 to 18.9. The CSF 
of A-C for capture of pigeons in this study was 2.2 and the 
extreme case analysis of CSF based on 95% fiducial limits 
indicated that the CSF ranged from 0.1 to 3.5 (Woronecki et 
al. 1991b). 
Only control pigeons and pigeons dosed at 1X (MED) 
and 3X were used for hematology and serum chemistry pro-
files. Blood values were similar to those reported by Woerpel 
and Rosskopf (1984) and Allen (1988) for normal pigeons. 
Samples from 1X and 3X pigeons were obtained on Days 1 
and 7 post-treatment. Gross and histological examination did 
not reveal a consistent morphological toxicity pattern in the 
dosed groups when compared with controls. 
Canada geese and pigeons The following clinical 
effects of A-C noted in this study were typical for both 
pigeons and waterfowl and were considered important indi-
cators of the stage of sedation, depth of sedation or anesthe-
sia, and dose received. Early stages of light sedation were 
characterized by the loss of equilibrium, blinking of eyes and 
torticollis. Midstage and deepening sedation leading to the 
point when the animal could be captured was typified by the 
closing of eyes, limited movement, and the bird becoming 
prostrate or supine. Deep anesthesia sometimes followed by 
death was exemplified by torticollis, fluid in the oral cavity 
and respiratory irregularity. Recovery was marked by rever-
sal of the previously described effects. As the dose rate in-
creased, onset of clinical effects generally occurred sooner 
and recovery time was longer (Table 2). Male Canada geese 
appeared to be affected more rapidly (t-test, P<0.02) than fe-
males, but in pigeons there was no difference (t-test, P<0.50) 
between the sexes (Table 3). Results of these laboratory 
studies are described in more detail in Woronecki et al. 
(1991b). 
Mallards Twenty-three of 24 mallards dosed at the 
Canada goose MED level of 30 mg/kg were capturable within 
69 minutes of dosing. There were no differences (t-test, 
P>0.20) between males and females in time to first symp-
toms or time to capturability. All mallards fully recovered 
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Table 2. Relationship between alpha-chloralose dose level and its effect on Canada geese and pigeons. 
 
 
within 24 hours (Table 3). Results of this laboratory study are 
described in more detail in Woronecki and Dolbeer (1991). 
Field Trials 
Waterfowl Thirty-one Canada geese and 556 nuisance 
ducks were removed from 8 situations in 4 states with 100 
and 92% survival, respectively (Table 4). Nuisance water-
fowl were generally accustomed to being fed, making 
prebaiting easy. Generally, bait formulations were based on 
1-kg wild mallards and 4-kg Canada geese. Bait formulation 
for feral ducks and geese and hybrid ducks were determined 
in the field by visually estimating weights relative to wild 
mallards and Canada geese. However, between and within 
sites there was considerable variation in duck and goose 
weights which contributed to some individuals receiving un-
der- or overdoses. Consumption of more than one treated 
bread bait also contributed to mortality. All baits were con-
sumed within 15 minutes after application and symptoms 
produced by A-C were usually noted within 30 minutes after 
ingestion. Most waterfowl were capturable 60 minutes after 
ingestion. Affected waterfowl were typically ignored by other 
waterfowl, which continued to feed or rest until affected. 
Birds not captured the first baiting readily accepted A-C baits 
in subsequent baitings without apparent bait shyness or 
chemical repellency. 
Trials in Ohio and Arizona using bread baits on nuisance 
ducks resulted in the exposure of baits to nontarget animals. 
In Ohio a ring-billed gull (Larus delawarensis) consumed a 
single treated bait and died shortly after being captured. In 
Arizona 4 nontarget animals [2 Koi goldfish, 1 black swan 
(Cygnus stratus) and 1 great-tailed grackle (Quiscalus 
mexicanus)] ingested A-C-treated bread baits but none were 
observed affected. However, we suspect that the grackle may 
have died from an overdose of A-C. 
Trials were favorably received by the general public as 
an effective and humane tool for capturing, removing or relo-
cating nuisance waterfowl. Most trials were in locations 
where the public could observe the operations. 
Pigeons In a preliminary, unaudited trial conducted in 
1989 at the University of Nevada Agricultural Experiment 
Station (UNAES) in Reno, using whole kernel com treated 
with 90% a.i. A-C (1 to 4 mg/kernel), 697 pigeons were 
removed from a dairy with 90% survival (Table 4). In audited 
trials, 673 pigeons were removed from locations in 2 states 
with 98% survival (Table 4). In 1990, at the UNAES, pigeons 
were baited with whole kernel corn treated with A-C on 6 
Table 3. Time to capturability (hours) for male and female Canada geese, mallards and pigeons dosed at the 
Most Effective Dose (MED) level (30 mg/kg - geese and mallards, 60 mg/kg - pigeons). 
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Table 4. Nuisance ducks, Canada geese and pigeons captured with alpha-chloralose (A-C) during field trials in 1990 and 1991. 
 
 
occasions over 4 days. A total of 64,000 treated kernels (1 mg 
A-C/kernel) were offered and 650 pigeons were captured 
with 2% mortality. All bait was consumed within 30 minutes 
of placement. Captured pigeons ingested an average of 39 
kernels, resulting in a mean dose of 115 mg A-C/kg of body 
weight. We suspect that many other pigeons obtained sub-
immobilizing doses. No hazards to nontarget wildlife were 
noted and no evidence of bait shyness developed after 4 con-
secutive days of baiting. This study demonstrated that A-C is 
an effective, safe means of capturing pigeons. 
In 1991, pigeons were baited on 2 days with whole ker-
nel corn treated with A-C (1 mg A-C/kernel) on 3 rooftops in 
downtown Mansfield, Ohio (Table 4). About 300 pigeons 
loafed in the downtown area daily. Bait acceptance was mod-
erate; 61% of the 18,000 treated kernels were consumed by 
pigeons within 5 hours of placement. But, only 23 pigeons 
were captured and all recovered from the effects of A-C. No 
nontarget birds fed at bait sites. We believe more pigeons 
would have been captured if a traditional feeding site had 
been used for baiting instead of traditional loafing sites. No 
negative public reaction was noted in any pigeon test. 
DISCUSSION 
Laboratory Studies 
Canada geese appear to be more susceptible to the ef-
fects of orally administered A-C (ED50 = 15.5 mg/kg, LD50 = 
53.9 mg/kg, TI = 3.5) than chickens in which the ED50 = 45 
mg/kg, LD50 = 300 mg/kg and TI = 6.7 (Loibl et al. 1988), 
but similar to mallards in which the ED50 = 14.8 mg/kg, LD50 
= 54.6 mg/kg, and TI = 3.3 (Woronecki, Unpubl. data). Pi-
geons, however, appear to be more resistant to the effects of 
A-C (ED50 = 30.53 mg/kg, LD50 = 215 mg/kg, TI = 7.04) 
than Canada geese. 
The CSF is useful in evaluating the safety of capture 
drugs, particularly when groups of animals must be caught 
without mortality. A drug with a CSF <1 is contra-indicated 
under such a requirement because the LD01 is less than the 
ED99. In the case of Canada geese where the LD01 is 0.7 of 
the ED99 (CSF = 0.7), this problem can be minimized be-
cause the number of bread baits ingested by individual geese 
can be controlled by selective baiting of individual birds. For 
pigeons (CSF = 2.23) the drug is safe, particularly in field 
applications of whole kernel corn baits in which the number 
of baits ingested by an individual bird cannot be controlled. 
With respect to minimum mortality being tolerated (e.g., 10% 
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= LD10/ED99), the CSF for geese is 1.02 and the CSF for 
pigeons is 2.93, indicating that the drug can be used safely on 
both geese and pigeons where minimal mortality is tolerable. 
Similar to the findings of Loibl et al. (1988) only 
torticollis, fluid in the oral cavity, respiratory irregularities 
and shivering were observed in A-C affected birds in this 
study. Tonic convulsions such as induced by strychnine poi-
soning (Lees 1972, Winters 1976), were not observed. The 
only convulsion-like behavior observed seemed to occur 
when animals in mid to deep sedation were disturbed or 
startled by other affected birds staggering within the holding 
cage. Overall, A-C-induced sedation did not appear to cause 
stress. Furthermore, untreated birds showed no negative 
response to birds in the same cage undergoing A-C-induced 
sedation. 
The MED derived for Canada geese (30 mg/kg) appears 
suitable for mallards and probably other waterfowl because 
100% of the mallards dosed at 30 mg/kg reached capturable 
stage with no mortality. The mean time to first effects was 
almost identical for mallards (33 minutes) and Canada geese 
(36 minutes). The mean time to capturability was less for 
mallards (52 minutes) than for Canada geese (90 minutes). 
Field Trials 
Trials involving waterfowl demonstrated the safety and 
efficacy of A-C at a dose rate of 30 mg/kg body weight. 
Waterfowl were successfully captured in 8 situations in 4 
states using bread or whole kernel corn baits with minimal 
(8% for ducks, 0% for geese) mortality and hazards to 
nontarget animals. Audited field trials with pigeons demon-
strated the effectiveness and safety of whole kernel com baits 
treated with 1 mg A-C/kernel of corn for capturing pigeons 
with negligible mortality and no hazards to nontarget ani-
mals. In addition, the general public and wildlife personnel 
accepted A-C as an effective and humane tool for capturing 
and removing waterfowl and pigeons. 
During laboratory trials we found that more control of 
dose levels is needed when baiting Canada geese and mal-
lards than pigeons. However, the hazard caused by this sus-
ceptibility can be minimized by selective baiting of individual 
birds with treated bread baits or providing an optimum num-
ber of treated corn baits per waterfowl present. Field trials 
reflect this susceptibility of waterfowl to A-C and support our 
laboratory data because some mortality occurred in most field 
trials. However, pigeons experienced minimum mortality 
during field studies when non-selective baiting was conducted 
using treated whole kernel corn baits. In some cases pigeons 
ingested 3 times the MED without dying. 
The trials also demonstrated that A-C can be safely used 
in high-traffic public areas where capture of waterfowl and 
pigeons is not possible by the traditional means of explosive 
or other propelled net devices or where trapping creates pub-
lic relations problems. In addition to the safety issues of using 
explosive net devices in public areas, netting or trapping of 
wild birds can produce significant physical trauma, e.g. bro-
ken wings and legs, cervical column damage to long neck 
birds, as well as stress-induced capture myopathy (Spraker et 
al. 1987). Although some mortality was experienced due to 
birds consuming excessive amounts of A-C, the overall mor-
tality was within acceptable limits when compared with more 
stressful procedures such as trapping, poisoning or shooting 
of birds. 
CONCLUSIONS AND STATUS OF FDA 
REGISTRATION 
The data from controlled laboratory and field studies 
substantiate that A-C is a safe capture agent for waterfowl 
when the amount of drug ingested by an individual bird is 
controlled and is a safe capture agent for pigeons even when 
the amount of drug or treated bait ingested by individual birds 
cannot be controlled. On 18 October 1991, copies of the New 
Animal Drug Application (INAD 6602) were submitted un-
der Expedited Review Status to the FDA Center for Veteri-
nary Medicine (CVM), Division of Drugs for Non-Food 
Animals. Included in the submission were: 1) identification 
data including the trade name "BIRDNAP", 2) a summary of 
chemistry, scientific rationale, and purpose of the new animal 
drug, and highlights of laboratory and field studies, 3) draft of 
the labelling, and 4) evidence of established safety and effi-
cacy (11 laboratory and field trial reports). Presently we are 
awaiting the outcome of the review but we expect registration 
in 1992 for use in applying baits for sedation and capture of 
waterfowl and feral pigeons by Federal and state wildlife 
biologists. 
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